Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults with extensive-stage small cell lung cancer that progressed on or after platinum-based chemotherapy.
LAMPGEN ANALYSIS
Why it matters
Randomized survival evidence converted the earlier accelerated approval of this DLL3-targeted bispecific antibody.
What research teams should watch
Review step-up dosing capacity and set clear inpatient and outpatient handoffs for cytokine release syndrome and neurotoxicity monitoring.
PRIMARY RECORDS